CT imaging biomarkers after neoadjuvant immunotherapy in resectable non-small cell lung cancer: from response assessment to surgical decision-making

Yu Li, Lan Wen

Open source

DOI
10.3389/fmed.2026.1949375
Published
2026-10-22
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1949375,
  title = {CT imaging biomarkers after neoadjuvant immunotherapy in resectable non-small cell lung cancer: from response assessment to surgical decision-making},
  author = {Yu Li and Lan Wen},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1949375},
  url = {https://doi.org/10.3389/fmed.2026.1949375}
}

RIS

TY  - JOUR
TI  - CT imaging biomarkers after neoadjuvant immunotherapy in resectable non-small cell lung cancer: from response assessment to surgical decision-making
AU  - Yu Li
AU  - Lan Wen
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1949375
UR  - https://doi.org/10.3389/fmed.2026.1949375
ER  - 

APA

Li, Y., & Wen, L. (2026). CT imaging biomarkers after neoadjuvant immunotherapy in resectable non-small cell lung cancer: from response assessment to surgical decision-making. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1949375

Source records